Area:
Molecular Biology, Cell Biology
We are testing a new system for linking grants to scientists.
The funding information displayed below comes from the
NIH Research Portfolio Online Reporting Tools and the
NSF Award Database.
The grant data on this page is limited to grants awarded in the United States and is thus partial. It can nonetheless be used to understand how funding patterns influence mentorship networks and vice-versa, which has deep implications on how research is done.
You can help! If you notice any innacuracies, please
sign in and mark grants as correct or incorrect matches.
Sign in to see low-probability grants and correct any errors in linkage between grants and researchers.
High-probability grants
According to our matching algorithm, William E. Roudebush is the likely recipient of the following grants.
Years |
Recipients |
Code |
Title / Keywords |
Matching score |
1997 — 1998 |
Roudebush, William E |
R03Activity Code Description: To provide research support specifically limited in time and amount for studies in categorical program areas. Small grants provide flexibility for initiating studies which are generally for preliminary short-term projects and are non-renewable. |
Embryonic Platelet Activating Factor @ Medical University of South Carolina
DESCRIPTION: (Adapted from applicant's description) The long-term goal of this project is to gain an understanding of the mechanism of platelet-activating factor's [1-O-alkyl-sn-acetyl-glycero-3-phosphocholine; PAF] action in the preimplantation embryo which facilitates implantation. PAF, a potent signaling phospholipid, has been implicated in a variety of reproductive processes. Embryo-derived PAF plays a crucial role in the establishment of pregnancy. However, the direct impact of PAF on preimplantation development is not known. The present proposal will attempt to address this issue with respect to the PAF-receptor mediated gene expression in CFW mouse embryos for the following reasons: First, 3H-PAF binds to CFW mouse embryos. In other sytems PAF through receptor interaction, induces phospholipase-C hydrolysis of phosphatidyl inositol 4,5-biphosphate to diacylglycerol and inositol 1,4,5-triphosphate, which results in calcium mobilization; and second, PAF exposure leads to increased blastocyst cell numbers suggesting that, analogous to observations in other cell systems, PAF can induce gene expression. The investigators hypothesize that embryo development involves the PAF stimulation of the embryonic receptor mediated inositol-triphosphate system and resultant gene expression thus affecting development. This highly reproducible murine-embryonic model presents the investigators with the opportunity to examine the extent by which PAF influences embryo development. There are three specific aims addressing these interests: SPECIFIC AIM 1 is to determine the kinetics of [3H]PAF binding to CFW mouse preimplantation embryos. SPECIFIC AIM 2 is to determine that CFW mouse preimplantation embryos express the PAF-receptor. SPECIFIC AIM 3 is to determine that PAF increases intracellular calcium levels in CFW mouse embryos. This proposal is relevant to human reproduction since human embryos produce PAF and this embryo-derived PAF mediates the maternal recognition of pregnancy and PAF production by human embryos is related to their subsequent pregnancy potential.
|
1 |